The Patent Finder

Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Solid State Forms Thereof

AbbVie Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 45 of these applications claim priority to application 15/295,561, filed Oct 17, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,879,018Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Solid State Forms Thereof
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 9,879,019Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-alpha]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 9,951,080Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Solid State Forms Thereof
In force
 · Medium confidence
AbbVie Inc.In force
Medium confidence
US 9,963,459Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2-alpla]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Solid State Forms Thereof
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 10,017,517Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Solid State Forms Thereof
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 10,202,393Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Solid State Forms Thereof
In force
 · Medium confidence
AbbVie Inc.In force
Medium confidence
US 10,202,394Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Solid State Forms Thereof
In force
 · Medium confidence
AbbVie Inc.In force
Medium confidence
US 10,344,036PROCESSES FOR THE PREPARATION OF (3S,4R)-3-Ethyl-4-(3H-IMIDAZO[1,2- a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-Trifluoroethyl)PYRROLIDINE-1- CARBOXAMIDE AND SOLID STATE FORMS THEREOF
In force
 · Low confidence
AbbVie Inc.In force
Low confidence
US 10,519,164Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
In force
 · Medium confidence
AbbVie Inc.In force
Medium confidence
US 10,550,126Processes for the Preparation of (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
In force
 · High confidence
AbbVie Inc.In force
High confidence
75 more patents in this group · Pro
10 of 85 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 85.
Upgrade to Pro
45 of these are in force and held by AbbVie Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited